Open Access Policy, Licensing & Copyright
The Journal of Breast Diseases, Kolkata follows an open access publishing model and adopts the Creative Commons Attribution License (CC BY 4.0 International License) for all published articles.
Under this license, users are permitted to read, download, copy, distribute, print, search, or link to the full texts of articles, and to use the material for any lawful purpose, including modification and commercial use, provided that appropriate credit is given to the original author(s) and the source of publication.
The CC BY 4.0 license is recognized internationally as a standard for open access publishing, ensuring maximum dissemination and reuse of scholarly work.
Copyright of all articles published in the Journal of Breast Diseases; Kolkata is retained by the author(s). By submitting and publishing their work in the journal, authors grant the journal a non-exclusive license to publish the article and to identify itself as the original publisher.
CC BY 4.0
Creative Commons Attribution License
Policy on the Use of Generative AI and AI-Assisted Technologies
The Journal of Institute of Breast Diseases, Kolkata (JIBDK) follows international publication ethics standards in line with recommendations from the International Committee of Medical Journal Editors (ICMJE) and the Committee on Publication Ethics (COPE).
This policy outlines the responsible and transparent use of generative Artificial Intelligence (AI) and AI-assisted technologies in manuscript preparation, peer review, and editorial decision-making.
JIBDK reserves the right to update this policy as AI technologies and ethical standards evolve.
1. Authorship and Responsibility
- AI tools cannot be listed as authors or co-authors
- AI tools cannot take responsibility for published work
- Authors remain fully responsible for the accuracy, originality, and integrity of their manuscript
- Use of AI does not reduce author accountability
2. Acceptable Use of AI
- Language editing and grammar improvement
- Formatting assistance
- Translation of text
- Technical coding or statistical assistance (with verification)
- Authors must review and verify all AI-generated content. AI should not replace scientific reasoning, data interpretation, or clinical judgment.
3. Prohibited Uses
- Undisclosed AI-generated text or content
- Fabrication or falsification of research data
- AI-generated references or citations without verification
- Manipulation of medical images without disclosure
- Uploading confidential patient or unpublished data into AI platforms
- Authors must comply with:
- Patient confidentiality standards
- Ethical approval requirements
- Data protection regulations
4. AI Disclosure Statement
- Authors must include an AI Usage Disclosure Statement in their manuscript.
- Example: "The authors used AI-assisted tools for language editing only. All content was reviewed and approved by the authors."
- If no AI used: "The authors declare that no AI-assisted technologies were used in this manuscript."
5. Editors and Reviewers
- Not upload manuscripts into public AI platforms
- Maintain confidentiality of submitted content
- Ensure editorial decisions remain human-driven
- Preserve scientific integrity during peer review
6. Policy Compliance
- Violation of this policy may lead to rejection, correction, or retraction in accordance with ethical publishing standards.
- JIBDK reserves the right to update this policy as AI technologies evolve.
Publication Ethics & Malpractice Statement
In order to carry out its mission, IRJMS develops ethical criteria. Participants in the editorial process are required to abide by these moral guidelines. Regarding the author’s perspective on the Journal’s pages, IRJMS adopts a neutral stance.
IRJMS abides by the guidelines made by the Committee on Publication Ethics (COPE), particularly the Guidelines on Good Publication Practise. These recommendations are taken into consideration by IRJMS’s editorial policy.
We used the Publishing Ethics Resource Kit (PERK) as a guide while creating the ethical guidelines.
Editors' Responsibilities
Publication Decisions
The editor is responsible for deciding which of the papers submitted to the International Research Journal of Multidisciplinary Studies (IRJMS) journal will be published. Papers may be rejected without review if the Editor considers the article obviously not suitable for publication. The editor will evaluate manuscripts without regard to the authors’ race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy. The decision will be based on the paper’s importance, originality and clarity, and validity of study and its relevance to the journal’s scope. Current legal requirements regarding copyright infringement, and plagiarism should also be considered.
Confidentiality
The editor and any editorial staff are not supposed to disclose any information about a submitted manuscript to anyone other than the corresponding author.
Disclosure and Conflicts of Interest
Unpublished materials disclosed in a submitted paper will not be used by the editor or the members of the editorial board for their own research purposes without the author’s unambiguous written consent.
Reviewers' Responsibilities
- Contribution to editorial decisions — The peer-reviewing process assists the editor and the editorial board in making editorial decisions and may also serve the author in improving the paper quality. All submitted manuscripts will be subject to strict peer-review process. High quality manuscripts will be blind peer-reviewed by minimum two reviewers of the same field.
- Promptness — Any selected referee who feels unqualified to review the research reported in a manuscript should notify the editor and withdraw from the review process.
- Confidentiality — Any manuscripts received for review must be treated as confidential documents. They must not be disclosed to or discussed with others without permission of editorial office.
- Standards of objectivity — Reviews should be conducted objectively. Reviewers should express their views clearly with supporting arguments.
- Acknowledgement of sources — Reviewers should recognize cases in which applicable published work referred to in the paper has not been cited in the reference section. They should point out whether explanation or arguments derived from other publications are accompanied by the proper source/ references.
- Disclosure and conflict of interest - Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions associated with the papers.
- Reporting standards — Authors of original research reports should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable.
- Data access and retention — Authors could be asked to provide the raw data of their study together with the paper for editorial review and should be ready to make the data in public accessible if possible. In any event, authors should ensure ease of access of such data to other competent professionals for at least ten years after publication.
- Originality, plagiarism and acknowledgement of sources — Authors should submit only entirely original works, and should appropriately cite or quote the work and/or words of others. Publications that have been influential in determining the nature of the reported work should also be cited.
- Multiple/redundant publication — Papers describing fundamentally the same research should not be published in more than one journal. Submitting the same manuscript to more than one journal simultaneously constitutes unethical publishing behavior and is unacceptable.Manuscripts which have been published as copyrighted material elsewhere cannot be submitted. In addition, manuscripts under review by the journal should not be resubmitted to copyrighted publications. However, by submitting a manuscript, the author(s) retain the rights to the published material.
- Authorship of the paper — Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. Submission of a paper to this journal indicates that the author(s) have agreed the content of the paper. One author should be indicated as corresponding author for all publication related communications. All correspondence and proofs would be sent to the corresponding author, who will be treated as final representative voice for all authors regarding any decision related to manuscript, unless otherwise requested during submission. JIBDK would not be responsible for any dispute related to authorship of a submitted paper. Any change in the authorship (such as addition or deletion of author(s) or change in the sequence of author list) should be intimated to the editorial office through a letter signed by all authors before publication of the paper. In absence of any signed letter, approval of ‘Galley proof’ by corresponding author will work as ‘certificate of final agreement of authorship’.
- Disclosure of conflicts of interest — Authors should disclose any financial or other substantive conflict of interest that might influence the results or interpretation of their manuscript and acknowledge individuals or organizations that have provided financial support for research.
- Fundamental errors in published works — When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the editorial office and cooperate with the editor to retract or correct the paper. we are creating our website for our journal JIBDK. We want to follow the ISSN guideline. please create for us the publication ethics.
JIBDK is committed to ensuring maximum visibility and discoverability of published research through participation in leading international indexing and abstracting services.
Scopus
Elsevier's abstract and citation database
Applied
PubMed / MEDLINE
National Library of Medicine, USA
Planned
Google Scholar
Free academic search engine by Google
Indexed
CrossRef (DOI)
DOI registration and citation linking
Indexed
Index Copernicus
International scientific indexing platform
Indexed
SCImago
Journal & country rankings portal
Applied
UGC CARE List
University Grants Commission India
Indexed
DOAJ
Directory of Open Access Journals
Planned
IndexedAppliedPlanned
Double-Blind Peer Review: JIBDK follows a transparent, fair, structured, and internationally accepted peer-review process. The journal follows a Double-Blind Peer Review System where both authors and reviewers remain anonymous.
1
Manuscript Submission
Authors submit through the online system. Incomplete submissions may be returned.
2
Initial Editorial Screening
Evaluation by the Editorial Office for suitability.
3
Plagiarism Check
Mandatory screening using professional detection software.
4
Assignment to Handling Editor
Editor assigned; assesses suitability and selects reviewers.
5
Reviewer Selection
Minimum two independent reviewers selected based on expertise and no conflicts of interest.
6
Peer Review Evaluation
Double-blind review with full confidentiality maintained.
7
Editorial Decision
Editor-in-Chief decision: Accept / Minor Revision / Major Revision / Reject.
8
Author Revision
Minor Revision: 7–14 days. Major Revision: 2–4 weeks. Point-by-point clarification required.
9
Final Decision
Editor evaluates revised manuscript; additional review may be conducted.
10
Post-Acceptance & Publication
Copyediting, proofreading, DOI assignment, online publication, issue allocation.
Fast-Track Review Process
JIBDK provides a Fast-Track Review Process for manuscripts requiring rapid publication due to scientific importance, clinical urgency, or policy relevance. This process accelerates publication without compromising scientific quality or ethical standards.
Purpose of Fast-Track Review
- Facilitate rapid dissemination of important clinical findings
- Publish urgent breast disease research
- Promote timely reporting of innovative clinical approaches
- Support emerging evidence in breast disease management
- Encourage high-impact clinical research
Request Requirements
- Clearly mention "Fast-Track Review Request" in the cover letter
- Provide justification for urgent review
- Ensure manuscript is complete and formatted per guidelines
- Submit all required documents at initial submission
Fast-Track Review Timeline
| Submission Acknowledgement |
24 hours |
| Editorial Screening |
48–72 hours |
| Reviewer Assignment |
72 hours |
| Peer Review |
5–7 days |
| Editorial Decision |
2–3 days |
| Final Decision |
7–14 days |
| Online Publication |
3–5 days after acceptance |
Important Notes
- Fast-track review does not guarantee acceptance
- Manuscripts undergo full peer review
- Editorial decision remains independent
- Fast-track requests may be declined based on scientific merit
- Ethical standards remain unchanged
Conflict of Interest Policy
JIBDK is committed to maintaining transparency, integrity, and unbiased decision-making. A conflict of interest exists when professional judgment concerning a manuscript may be influenced by financial, personal, academic, or professional relationships.
Authors
- Financial support or funding
- Employment or institutional affiliations
- Consultancy, honoraria, or advisory roles
- Patents or stock ownership
- Personal or professional relationships
Reviewers
- Personal or professional relationship with authors
- Financial or academic competition
- Any potential bias affecting objectivity
- Must maintain confidentiality and not use unpublished material for personal benefit
Editors
- Avoid handling manuscripts where conflicts exist
- Delegate editorial decisions when conflicts arise
- Maintain confidentiality of submitted manuscripts
- Avoid using unpublished information for personal gain
- Editors submitting to JIBDK will not be involved in decision-making for their own submissions
All conflicts of interest must be disclosed at the time of submission. Failure to disclose relevant conflicts may result in rejection, correction, or retraction of the manuscript. JIBDK follows ICMJE and COPE ethical standards.
The Journal of Institute of Breast Diseases, Kolkata (JIBDK) is committed to maintaining high standards of academic integrity and originality. The journal follows ethical publishing practices in accordance with ICMJE and COPE guidelines and requirements for ISSN and indexing standards.
Plagiarism includes:
- Copying text from another source without proper citation
- Using ideas, data, or results without acknowledgment
- Copying tables, figures, or images without permission or citation
- Submitting another persons work as ones own
- Self-plagiarism or redundant publication
- Similarity Check
All manuscripts submitted to JIBDK are screened for plagiarism using reliable plagiarism detection software such as Turnitin, iThenticate, or similar tools.
Authors must confirm that:
- The manuscript is original
- The work has not been published previously
- The manuscript is not under consideration elsewhere
- Editorial Responsibility
The editorial board of JIBDK ensures:
- Fair and transparent plagiarism screening
Confidential handling of manuscripts
Ethical decision-making in accordance with COPE guidelines
Policy on Originality
All manuscripts submitted to JIBDK must be original and unpublished work. Authors must ensure that their submission is free from plagiarism, data fabrication, falsification, and redundant publication.
JIBDK maintains a zero-tolerance policy for plagiarism and is committed to promoting ethical and responsible scientific publishing.
Types of Plagiarism
Direct Plagiarism
Copying text word-for-word from another source without citation.
Self-Plagiarism
Reusing previously published work without proper reference or justification.
Mosaic Plagiarism
Mixing copied phrases from different sources without proper attribution.
Data & Image Plagiarism
Using figures, tables, or images without proper permission or citation.
Similarity Index Thresholds
Similarity index below 10%
Acceptable — proceed to review
If similarity index is between 10–25%
Authors may be asked to revise and reduce similarity
If similarity index is above 25–30%
The manuscript may be rejected without review
Above 30%
Immediate rejection without review
Before Publication
- Manuscript rejection
- Request for revision
- Author notification
After Publication
- Article retraction
- Publication of correction or retraction notice
- Notification to author’s institution (if required)
- Author Declaration
Article Processing Charges (APCs)
JIBD does not charge any fee for manuscript submission. All submitted manuscripts undergo editorial screening and peer review without any initial payment.
Publication Charges:
This fee may be paid by the author(s), institution(s), funding agency, or employer(s).
All articles published in JIBDK are fully open access, allowing readers worldwide to freely access, download, and share published content.
JIBD follows ISSN guidelines and standard ethical publishing practices, ensuring transparency, fairness, and academic integrity in all publication processes.
Article Processing Charge
₹2,000
Indian Rupees (INR) only
Applicable only after acceptance of the manuscript for publication.
No Charges For
No submission fees
No fees for rejected manuscripts
No hidden charges
No charges during peer review
Payment details will be shared only after acceptance through the official acceptance email. This fee may be paid by the author(s), institution(s), funding agency, or employer(s).
The Journal of Institute of Breast Diseases, Kolkata (JIBDK) is committed to the long-term preservation and accessibility of its published content. All articles are securely archived in the journal’s digital repository and cloud storage to ensure permanent access for researchers, clinicians, and readers.
JIBDK follows ISSN and international digital preservation best practices and aims to participate in recognized archiving services and preservation systems. The journal also supports inclusion in preservation registries to ensure continued availability of published content for future scholarly use.
The Journal of Institute of Breast Diseases Kolkata (JIBDK) is committed to fair and transparent editorial practices. Authors, reviewers, and readers may submit complaints or appeals regarding editorial decisions, peer review, or publication policies.
1
Submit Complaint
Send detailed complaint to editor@jibdk.com with all relevant information.
2
Reference Number
Each complaint is assigned a unique reference number for tracking.
3
Acknowledgement
Complaint acknowledged within 3 working days.
4
Investigation & Resolution
Handled confidentially, fairly, and promptly per ISSN and international publishing best practices.
The Journal of Institute of Breast Diseases, Kolkata (JIBDK) takes publication ethics seriously and follows ISSN and COPE guidelines in handling research misconduct. Concerns related to suspected ethical violations before or after publication should be reported to the Editorial Office. The identity of complainants will be kept confidential, if requested.
The journal will conduct a fair and thorough investigation. Authors may be asked to provide supporting data, documents, or clarifications. Cases of misconduct may include, but are not limited to, plagiarism, duplicate submission, data fabrication or falsification, authorship disputes, and citation manipulation.
If misconduct is confirmed, the journal may take appropriate actions, including:
Cases of Misconduct
- Plagiarism and self-plagiarism
- Duplicate or concurrent submission
- Data fabrication or falsification
- Authorship disputes
- Citation manipulation
- Image manipulation without disclosure
Possible Actions
- Rejection of the manuscript
- Withdrawal of accepted or online-first articles
- Retraction of published articles following COPE Retraction Guidelines
- Notification to authors’ institutions or funding agencies
- Temporary restriction on future submissions (1–3 years)
- Minor unintentional errors may be corrected through corrigendum (author error) or erratum (publisher error).
The Journal of Institute of Breast Diseases (JIBD) is committed to protecting the privacy and confidentiality of authors, reviewers, and readers. Personal information such as names, email addresses, and affiliations collected by the journal will be used solely for editorial and publication purposes.
This information will not be shared with third parties or used for any other purpose, except as necessary for the publication process and in accordance with ISSN and international publishing ethical guidelines.
All personal data will be handled securely and confidentially.
Advertising & Direct Marketing
Advertising Policy
The Journal of Institute of Breast Diseases (JIBD) may include limited advertising or promotional content on its website to support journal operations. All advertisements will be clearly separated from editorial content, and advertising will not influence editorial decisions, peer review, or publication policies. Advertisements will not be placed within published articles.
Direct Marketing Policy
JIBD may also conduct direct marketing to inform researchers, clinicians, and institutions about the journal’s scope and publications. All marketing activities will follow ISSN and international ethical publishing standards, ensuring accuracy, transparency, and respect for privacy.